[go: up one dir, main page]

MX2020001363A - Gel comprising chlorhexidine. - Google Patents

Gel comprising chlorhexidine.

Info

Publication number
MX2020001363A
MX2020001363A MX2020001363A MX2020001363A MX2020001363A MX 2020001363 A MX2020001363 A MX 2020001363A MX 2020001363 A MX2020001363 A MX 2020001363A MX 2020001363 A MX2020001363 A MX 2020001363A MX 2020001363 A MX2020001363 A MX 2020001363A
Authority
MX
Mexico
Prior art keywords
chlorhexidine
gels
pharmaceutically acceptable
acceptable salt
oral cavity
Prior art date
Application number
MX2020001363A
Other languages
Spanish (es)
Inventor
Balasch Risueño Joaquín
Embid López Marta
Original Assignee
Laboratorios Kin S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Kin S A filed Critical Laboratorios Kin S A
Publication of MX2020001363A publication Critical patent/MX2020001363A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A61K8/416—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to a gel composition comprising chlorhexidine and/or a pharmaceutically acceptable salt thereof; hyaluronic acid and/or a pharmaceutically acceptable salt thereof; and a gelling matrix, wherein the gelling matrix comprises water, and cellulose derivatives. The invention also relates to a method for preparing the gels and to particular uses of the gels in the field of oral cavity cosmetics, hygiene, prevention of oral cavity diseases and treatment of said diseases.
MX2020001363A 2017-08-04 2018-08-03 Gel comprising chlorhexidine. MX2020001363A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17382547 2017-08-04
IE20170230A IE87094B1 (en) 2017-08-04 2017-11-02 Gel comprising chlorhexidine
PCT/EP2018/071155 WO2019025599A1 (en) 2017-08-04 2018-08-03 Gel comprising chlorhexidine

Publications (1)

Publication Number Publication Date
MX2020001363A true MX2020001363A (en) 2020-03-20

Family

ID=63047391

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020001363A MX2020001363A (en) 2017-08-04 2018-08-03 Gel comprising chlorhexidine.

Country Status (11)

Country Link
EP (1) EP3661480A1 (en)
CN (1) CN110996891B (en)
BR (1) BR112020002106B1 (en)
CL (1) CL2020000293A1 (en)
CR (1) CR20200058A (en)
IE (1) IE87094B1 (en)
MX (1) MX2020001363A (en)
NI (1) NI202000007A (en)
PE (1) PE20200698A1 (en)
PH (1) PH12020550032A1 (en)
WO (1) WO2019025599A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020248232A1 (en) * 2019-06-14 2020-12-17 The Procter & Gamble Company Leave-on oral care compositions
BR112021024271A2 (en) 2019-06-14 2022-01-11 Procter & Gamble Compositions for rinse-free oral care
EP3982917A1 (en) 2019-06-14 2022-04-20 The Procter & Gamble Company Leave-on oral care compositions
WO2020248239A1 (en) * 2019-06-14 2020-12-17 The Procter & Gamble Company Leave-on oral care compositions
EP3982912A1 (en) 2019-06-14 2022-04-20 The Procter & Gamble Company Leave-on oral care compositions
CN111494376A (en) * 2020-06-15 2020-08-07 牡丹江医学院 Medicine for treating gingivitis and preparation method thereof
IT202000029288A1 (en) 2020-12-01 2022-06-01 Altergon Sa BIGUANIDINE MICROBIOCIDE SALTS WITH GLYCOSAMINOGLYCANS
WO2022251438A1 (en) * 2021-05-26 2022-12-01 Colgate-Palmolive Company Oral care compositions
CN113440441B (en) * 2021-07-29 2022-09-16 山东福瑞达生物股份有限公司 Oral bacteriostatic composition containing essential oil and preparation method thereof
EP4483889A1 (en) 2023-06-28 2025-01-01 Igen Biolab Group AG Postbiotic composition for oral administration for preventing or treating oral dysbiosis
GR1010853B (en) * 2023-11-10 2025-01-10 Ιουλια Τσετη Composition of sodium hyaluronate and sucralphate for administration into the oral cavity
CN119033680A (en) * 2024-08-28 2024-11-29 西南医科大学附属口腔医院 Preparation method and application of hydrogel for oral mucosa injury
CN120309762B (en) * 2025-04-29 2026-01-06 杭州三言生物科技有限公司 A method for preparing chlorhexidine hyaluronic acid with antibacterial properties

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192802A (en) 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
CH691030A5 (en) 1995-09-26 2001-04-12 Apr Applied Pharma Res Sa A gel formulation, for topical use in the pharmaceutical, cosmetic, dietetic and veterinary industries
JPH1160505A (en) 1997-05-20 1999-03-02 Senju Pharmaceut Co Ltd Antiseptic composition
US6117415A (en) 1999-06-17 2000-09-12 Alpharx Inc. Toothpaste comprising bioadhesive submicron emulsion for improved delivery of antibacterial and anticaries agents
US8283135B2 (en) * 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
RU2286764C1 (en) 2005-06-16 2006-11-10 Георгий Георгиевич Ростиашвили Agent of prolonged action for treatment of mouth cavity inflammation diseases
US8609634B2 (en) 2007-05-16 2013-12-17 Mcneil-Ppc, Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
US20090068122A1 (en) * 2007-09-06 2009-03-12 Shira Pilch Dentifrice Compositions for Treating Xerostomia
EP2520279A1 (en) * 2011-05-02 2012-11-07 TERES S.r.l. Thermoreversible gel pharamaceutical compositions for odontoiatric use
CN104474582A (en) * 2014-12-17 2015-04-01 安徽省健源医疗器械设备有限公司 Hyaluronic-acid-containing hemostatic gauze and preparation method thereof
ES2795356T3 (en) * 2015-05-08 2020-11-23 Curasept Ads S R L Preparation of improved mouthwashes
CN105342939A (en) * 2015-12-15 2016-02-24 山东消博士消毒科技股份有限公司 Disinfectant bath wash capable of reducing operative incision infection and preparation technology of disinfectant bath wash
CN106540281A (en) * 2016-12-08 2017-03-29 邓丽萍 B ultrasonic couplant and its preparation technology

Also Published As

Publication number Publication date
BR112020002106A8 (en) 2020-12-01
CN110996891B (en) 2023-02-28
NI202000007A (en) 2020-07-31
CN110996891A (en) 2020-04-10
PE20200698A1 (en) 2020-06-16
CR20200058A (en) 2020-03-28
WO2019025599A1 (en) 2019-02-07
EP3661480A1 (en) 2020-06-10
IE87094B1 (en) 2020-05-13
BR112020002106A2 (en) 2020-08-04
BR112020002106B1 (en) 2023-04-18
IE20170230A1 (en) 2019-02-06
PH12020550032A1 (en) 2021-02-15
CL2020000293A1 (en) 2020-08-14

Similar Documents

Publication Publication Date Title
PH12020550032A1 (en) Gel comprising chlorhexidine
PH12020500066A1 (en) Carboxamides as modulators of sodium channels
MX2022011676A (en) Masked il12 fusion proteins and methods of use thereof.
MX2021002321A (en) Novel methods.
WO2018198077A3 (en) 6-6 fused bicyclic heteroaryl compounds and their use as lats inhibitors
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
MX368504B (en) Amide derivatives and pharmaceutically acceptable salts thereof, preparation method therefor and medicinal application thereof.
PH12012500756A1 (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions
MX2011008616A (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions.
MX337830B (en) Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions.
BR112015022161A2 (en) prostamide-containing intraocular implant
TN2015000520A1 (en) Pharmaceutical compositions comprising collagen and sodium hyaluronate
AU2018231044A8 (en) Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol
PH12017501304A1 (en) Levodopa and carbidopa intestinal gel and method of use
BR102015001449B8 (en) composition of papain dental gel for non-traumatic treatment of cavities and method for its preparation
MX2020007062A (en) Cerdulatinib-containing topical skin pharmaceutical compositions and uses thereof.
MD3905G2 (en) Remedy of durable action in the form of gel for treatment of parodentium affections (variants)
DE602004019528D1 (en) COMPOSITIONS FOR TREATING RECURRENT APHTHS IN THE MOUTH VALVE
PH12015501251A1 (en) Compositions and methods for treating dental caries
WO2018158542A8 (en) Mesenchymal stem cells obtained from wharton's jelly for the treatment of sepsis
EP4620940A3 (en) Synthesis of (+)-cannabinoids and their therapeutic effects
IL250852B (en) Periodontal composition
MY196333A (en) Intranasal Composition Comprising Betahistine
EA202091062A1 (en) CARBOXYLCHITOSAN
RU2011143735A (en) MEANS FOR SKIN WHITENING AND COSMETIC METHOD FOR WHITENING SKIN